Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.64 +0.07 (+0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Other Accumulated Expenses (2019 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) posted Other Accumulated Expenses of $60.78 million for Q2 2026, up 69.8% from $35.78 million a year earlier and up 45.0% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Harmony Biosciences Holdings' Other Accumulated Expenses came in at $65.82 million, up 27.2% from FY2024.

  • Annual Other Accumulated Expenses has increased for six consecutive years, with a five-year compound annual growth rate of 48.9% (FY2020 to FY2025).
  • In prior years, Harmony Biosciences Holdings' Other Accumulated Expenses was $51.75 million in FY2024 (+28.0%), $40.42 million in FY2023 (+59.3%), $25.37 million in FY2022 (+54.7%) and $16.4 million in FY2021 (+82.1%).
  • Quarterly Other Accumulated Expenses has run from a low of $7.61 million in Q2 2024 to a high of $65.82 million in Q4 2025 over five years.
  • On a year-over-year basis, Other Accumulated Expenses has increased in each of the last seven quarters, with growth averaging 109.8% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2025, with growth of 383.7%; the weakest was Q2 2024, with a decline of 66.2%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $41.91 million (Q1 2026), $65.82 million (Q4 2025) and $57.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Harmony Biosciences Holdings 2.30 Bn -452.73 Mn 198.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.78 Mn
Mar 31, 2026 41.91 Mn
Dec 31, 2025 65.82 Mn
Sep 30, 2025 57.32 Mn
Jun 30, 2025 35.78 Mn
Mar 31, 2025 29.56 Mn
Dec 31, 2024 51.75 Mn
Sep 30, 2024 11.85 Mn
Jun 30, 2024 7.61 Mn
Mar 31, 2024 25.09 Mn
Dec 31, 2023 40.42 Mn
Sep 30, 2023 29.67 Mn
Jun 30, 2023 22.54 Mn
Mar 31, 2023 19.06 Mn
Dec 31, 2022 25.37 Mn
Sep 30, 2022 20.94 Mn
Jun 30, 2022 17.13 Mn
Mar 31, 2022 13.65 Mn
Dec 31, 2021 16.40 Mn
Sep 30, 2021 13.20 Mn
API Access

Harmony Biosciences Holdings Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=HRMY&period=max&api_key=YOUR_API_KEY